Tune in to our radio show on your local public radio station, or sign up for the podcast and listen at your leisure. Here’s what it’s about:
More than 100 years ago, a New York surgeon named William Coley developed an unusual cancer treatment that produced a high fever in his patients. Although the treatment was unconventional, it turned out to be successful surprisingly often. Should Coley’s treatment be revived today? How else might we jump-start the immune system? Find out about the hope for vaccine treatments for cancer, as well as the status of Coley’s fluid. This is the second in a three-part series on unconventional approaches to cancer.
Guests: Don MacAdam, CEO of MBVax Bioscience in Ancaster, Ontario, Canada. Online at MBvax.com
Jonathan Serody, MD, Elizabeth Thomas Professor of Medicine, Microbiology and Immunology in the Program in Stem Cell Transplantation. He is Director of the LCCC Program in Malignant Hematology and Co-leader of the LCCC Immunology Program at the University of North Carolina at Chapel Hill. The photo is of Dr. Serody.
The podcast of this program will be available the Monday after the broadcast date. Podcasts can be downloaded for free for six weeks after the date of broadcast. After that time has passed, digital downloads are available for $2.99. CDs may be purchased at any time after broadcast for $9.99.
